Cognitive Musical Screening and Therapeutic Innovation in Multiple Sclerosis

Sponsor
Hunter College of City University of New York
Study ID
NCT07552428
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Musical tool (Ipsilon) — BEHAVIORAL
    The musical tool to assess cognitive function

Study Details

This pilot study evaluates the effectiveness of screening and improving cognitive function in patients with multiple sclerosis (MS) using a musical tool, the Ipsilon. The Ipsilon performance will be compared with established neuropsychological assessments, including the Minimal Assessment of Cognitive Function in MS (MACFIMS) and the Processing Speed Test (PST). Thirty-two participants will be enrolled in a crossover design: half will complete the Ipsilon musical test for 15 minutes daily for seven consecutive days, while the other half will begin with no intervention before switching sequences. Participants will undergo screening for depression, colorblindness, musical background, and upper extremity function. Primary outcomes include evaluating whether the Ipsilon more reliably predicts cognitive domains measured by MACFIMS than the PST and assessing its potential to improve cognitive function. Secondary outcomes will examine associations with work functioning and quality of life.

Key Dates

First listed
Apr 27, 2026
Start date
Oct 1, 2026
Status verified
Mar 2026
Primary completion
Oct 1, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
32 participants (estimated)

Arms

  • Arm: Crossover design: Group 1 initial Intervention - Ipsilon musical tool
    Group 1 starts with the musical tool for 15 minutes x 7 days
  • Arm: Crossover design: Control arm starts without any intervention.
    The control arm starts with no intervention.

Primary Outcome Measure

Cognitive function by the MInimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) [ Time Frame: Baseline, 1 week and 2 weeks ]

Central Contacts

Find similar trials

Nationwide
Multiple sclerosis trialsNeurology trialsBrain disorders trialsAutoimmune disease trials

Related Studies